A high-end vaccine and biological preparation company located in Hsinchu Biomedical Park.

(File photo, photo by reporter Liao Xueru)

[Reporter Wen Yude/Taipei Report] The Shilin District Prosecutor's Office is investigating cases involving insider trading and irregular transactions involving high-end companies and their "parent company" Chia Corporation. There are a total of 16 residences of the two companies in Asia and related criminal suspects. Although it is inconvenient for the prosecution to disclose the identity of the suspects, it is certain that the high-end chairman Zhang Shizhong has been interviewed, and other high-end executives such as director Zhang Genhu and general manager Chen Canjian , I am afraid they are all on the interview list.

The high-end stock price rose from a minimum of 83 yuan on October 26 of the previous year to a maximum of 417 yuan on May 17 last year. In addition, there was a report on June 8 last year that after the Philippines intends to purchase high-end vaccines, the high-end stock price climbed from 228 yuan to the same month. 283 yuan on the 15th, but after the Philippines denied it on the 16th of the same month, the stock price immediately fell to 260 yuan, causing people to question the abnormality of high-end stock price transactions.

Please read on...

Fei Hongtai, the chief summoner of the Kuomintang, mentioned at a press conference on October 18 last year that the high-end capital increase case in August last year (referring to 2020) was rejected by the securities counter buying center, and the capital increase was agreed in September. The capital increase was completed in January; among them, the document was returned in August and agreed in September. There was an irrelevant statement in the middle, and the inspection and investigation should be carefully investigated.

Fei Hongtai emphasized that at the end of November last year (referring to 2020), he received news that more than 10 legislators were involved in speculating in high-end stocks. He questioned that the price difference of high-end stocks from January last year (referring to 2020) to May this year was 13 times higher. , the high-end original capital is 2.1 billion yuan, and the market value reached 80 billion yuan at the highest. Is there any problem?

The People's Procuratorate stated at the time that after the High Prosecutor's Office sent in June this year (referring to 2021) to investigate the suspected violation of the Securities Exchange Act in high-end stock transactions, the case was immediately assigned to the chief prosecutor of the Major Economic Crimes Special Team for investigation, and a special case team was established. , commanded the Taipei City Investigation Bureau to carry out an in-depth investigation. In addition to conducting several special meetings, it also contacted the Financial Supervision and Administration Commission of the competent authority and the Counter Buying Center, and asked them to assist in the investigation and analysis of relevant materials and submit an analysis report as a reference.

High-end vaccines and its parent company, Genea Biotech, are involved in insider transactions. Today, the investigation and investigation will be divided into 16 groups to search and interview.

The picture shows a high-end vaccine production line.

(File photo, photo by reporter Huang Meizhu)